On Thursday, Sarepta Therapeutics Inc (SRPT) stock saw a modest uptick, ending the day at $122.41 which represents a slight increase of $4.42 or 3.75% from the prior close of $117.99. The stock opened ...

Supporters of the Arkansas Voter Integrity Initiative filed nine lawsuits and only won two, both of which could still be ...

The "Nucleic Acid Therapeutics CDMO Market Size, Share & Trends Analysis, 2024-2030" report has been added to ...

Since the FDA cleared Sarepta Thereapeutics' gene therapy for nearly all people with Duchenne, its stock price has tanked.

Analyst Uy Ear from Mizuho Securities maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report) and keeping the price ...

Prime Medicine's layoffs are part of a pattern. At least a half-dozen gene-editing companies have laid off staff in the past ...

Sarepta Therapeutics Inc (SRPT) stock saw a modest uptick, ending the day at $120.4 which represents a slight increase of $1.64 or 1.38% from the prior close of $118.76. The stock opened at $119.91 ...

The Fort Worth Police honored the late Detective W. T. Wise on the anniversary of his death in 1884, recalling his heroic actions and legacy.

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $177.83, a high ...

Capricor Therapeutics (NASDAQ:CAPR) stock rallied 20% Friday afternoon following news the company plans to present long-term ...